Myalgic Encephalomyelitis/Chronic Fatigue Syndrome: the biology of a neglected disease.
Arron, Hayley E, Marsh, Benjamin D, Kell, Douglas B et al. · Frontiers in immunology · 2024 · DOI
Quick Summary
This review examines what we know about ME/CFS by looking at how the disease develops from a combination of genetic factors, infections, and immune problems. The researchers found that ME/CFS appears to result from multiple body systems going wrong at the same time—including the immune system, inflammation, digestive health, and energy production. The study argues that doctors and scientists need to stop looking at ME/CFS as a single problem and instead understand it as a complex condition involving many interconnected issues.
Why It Matters
This review is important because it provides a comprehensive framework for understanding ME/CFS complexity, which may help guide future research and clinical approaches. By demonstrating how genetic, immune, inflammatory, and metabolic factors interconnect, it could lead to better diagnostic strategies and more targeted therapeutic interventions. This holistic model validates the experiences of patients who recognize their condition as multisystem illness rather than a single defect.
Observed Findings
- ME/CFS involves dysregulation of immune function with abnormal cytokine profiles and inflammatory markers
- Viral infections are commonly reported as disease triggers in patient histories
- Gut dysbiosis and altered microbiome composition are associated with ME/CFS
- Metabolic disturbances including impaired energy metabolism have been documented
- No standardized diagnostic criteria currently exist across medical guidelines
Inferred Conclusions
- ME/CFS emerges from an interconnected web of genetic vulnerabilities, environmental triggers, and multiple pathological responses rather than a single etiology
- A multifactorial model better explains ME/CFS complexity than previous single-system perspectives
- Future research and clinical management must adopt holistic, integrated approaches rather than fragmented disease models
- The scientific community requires paradigm shift in how ME/CFS is conceptualized, studied, and treated
Remaining Questions
- Which specific genetic variants predispose individuals to ME/CFS and how do they interact with environmental triggers?
- What is the temporal sequence of pathological events—which mechanisms initiate disease versus which are secondary consequences?
- How can standardized diagnostic criteria be established given the heterogeneity of presentations and underlying pathways?
- Which therapeutic interventions targeting immune dysregulation, inflammation, dysbiosis, or metabolism would be most effective and for which patient subgroups?
What This Study Does Not Prove
This review does not establish causation for any specific ME/CFS mechanism—it synthesizes existing evidence rather than generating new experimental data. It cannot determine which factors are primary drivers versus secondary consequences of disease, nor does it provide definitive diagnostic biomarkers or proven treatments. The authors acknowledge that diagnostic criteria variation across studies limits the strength of evidence for any single pathway.
Topics
Tags
Metadata
- DOI
- 10.3389/fimmu.2024.1386607
- PMID
- 38887284
- Review status
- Editor reviewed
- Evidence level
- Established evidence from major reviews, guidelines, or evidence maps
- Last updated
- 7 April 2026